tirzepatide not available In adults with obesity but diabetes, leads to significantly greater weight loss than semaglutide over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL FDA confirms tirzepatide shortage is

Among first-time prescriptions for which use could be established, ADMs accounted for 86.6% and AOMs accounted for 13.4%

Recent research has identified GD3 ganglioside as a pivotal senescence immune checkpoint

Getting the brand name right on the prescription matters

Introduction Evidence from trials and real-world studies in patients with type 2 diabetes (T2D) indicates that the risk of complications may be reduced by providing sustained glycemic control and that near-normal glycated hemoglobin (HbA 1c ) levels should be achieved as early as possible in the T2D trajectory (1, 2)

The recommended diluent is 0.9% Sodium Chloride injection (0.9% NaCl)